EPHX4
Epoxide hydrolase 4
Also known as: ABHD7, EH4, EPHX4_HUMAN, EPHXRP, FLJ90341
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUS5
- Gene
- EPHX4
- Ensembl
- ENSG00000172031
- Chromosome
- 1
- Canonical length
- 362 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
Predicted to enable hydrolase activity. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>Q8IUS5|EPHX4
1 MARLRDCLPR LMLTLRSLLF WSLVYCYCGL CASIHLLKLL WSLGKGPAQT FRRPAREHPP
61 ACLSDPSLGT HCYVRIKDSG LRFHYVAAGE RGKPLMLLLH GFPEFWYSWR YQLREFKSEY
121 RVVALDLRGY GETDAPIHRQ NYKLDCLITD IKDILDSLGY SKCVLIGHDW GGMIAWLIAI
181 CYPEMVMKLI VINFPHPNVF TEYILRHPAQ LLKSSYYYFF QIPWFPEFMF SINDFKVLKH
241 LFTSHSTGIG RKGCQLTTED LEAYIYVFSQ PGALSGPINH YRNIFSCLPL KHHMVTTPTL
301 LLWGENDAFM EVEMAEVTKI YVKNYFRLTI LSEASHWLQQ DQPDIVNKLI WTFLKEETRK
361 KDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EPHX4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 14 nTPM
- basal ganglia: 10 nTPM
- choroid plexus: 6.6 nTPM
- amygdala: 4.1 nTPM
- hippocampal formation: 2.6 nTPM
- midbrain: 2.3 nTPM
Single-cell type
- retinal amacrine cells: 42 nCPM
- brain inhibitory neurons: 37 nCPM
- retinal ganglion cells: 23 nCPM
- brain excitatory neurons: 20 nCPM
- endometrial secretory cells: 13 nCPM
- smooth muscle cells: 12 nCPM
Immune cell
- gdT-cell: 12 nTPM
- memory CD8 T-cell: 3 nTPM
- naive CD8 T-cell: 2.8 nTPM
- MAIT T-cell: 2 nTPM
- total PBMC: 1.5 nTPM
- memory CD4 T-cell: 1.4 nTPM
Brain region
- cerebral cortex: 22 nTPM
- basal ganglia: 19 nTPM
- choroid plexus: 13 nTPM
- white matter: 12 nTPM
- amygdala: 7.9 nTPM
- pons: 6.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.06
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EPHX4 as an antibody target. Whether an autoantibody or antibody against EPHX4 could matter depends on whether native EPHX4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EPHX4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EPHX4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...